Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.118473
Revised: March 5, 2026
Accepted: March 17, 2026
Published online: May 27, 2026
Processing time: 110 Days and 4.8 Hours
Improved survival after gastric cancer (GC) surgery has shifted clinical attention toward persistent non-organic symptoms, including cancer-related fatigue (CRF) and functional gastrointestinal disorders (FGIDs). These conditions frequently emerge during routine follow-up yet remain underrecognized and undertreated. This study reports a case of concurrent CRF and FGID after total gastrectomy and reviews relevant literature to clarify diagnostic considerations, underlying pathophysiological mechanisms, and multidisciplinary management strategies.
Clinical records, laboratory data, imaging findings, endoscopic results, and follow-up information were retrospectively analyzed. Fatigue severity was assessed using a numeric rating scale, and differential diagnoses excluded organic etiologies, including tumor recurrence and mechanical obstruction. A 55-year-old woman developed persistent postprandial abdominal pain and fatigue after total gastrectomy and perioperative chemotherapy. Her highest fatigue score reached 6/10, significantly impairing daily activities. Although multidimensional fatigue instruments were not used, clinical manifestations met the diagnostic criteria for CRF after exclusion of secondary causes. Gastrointestinal symptoms were con
Recognizing CRF and postoperative FGID after GC surgery requires systematic assessment and integrated multidisciplinary strategies to improve long-term postoperative outcomes.
Core Tip: Cancer-related fatigue and functional gastrointestinal disorders (FGID) frequently coexist in patients after gastric cancer (GC) surgery, particularly following total gastrectomy. Their clinical manifestations are insidious, heterogeneous, and often overlooked once tumor recurrence has been excluded. This case underscores the importance of comprehensive differential diagnosis, multidisciplinary management, and holistic symptom assessment that extends beyond oncological surveillance. Early recognition and individualized intervention for cancer-related fatigue and FGIDs are crucial for improving long-term outcomes and enhancing the quality of life in post- GC surgery patients.